By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
Company Description Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
Bayer in Basel is seeking a Senior HEOR Manager for COAs and PROs to lead strategic COA plans across therapeutic areas, guiding trials and contributing to regulatory submissions.You will collaborate with internal teams and external vendors, ensure
Revolution Medicines in Switzerland seeks a Senior Director, Epidemiology, Europe to lead regional epidemiology strategy and evidence generation across the product lifecycle.You will partner with Clinical Development, Global Patient Safety, Medical Affairs, Regulatory, RWE/HEOR, and Market Access
The Chief Medical Officer (CMO) for Venous Pressure Solutions will serve as the clinical, scientific, and strategic leader driving the validation, adoption, and scaling of the solution. This executive will oversee clinical positioning, medical affairs, evidence
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by
Who We Are: Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed
Bayer is seeking a Senior HEOR Manager for Patient-Reported Outcomes on a 12-month contract in Basel. You will lead COA strategy, guide trial planning, and manage external vendors to ensure regulatory-ready COA data across programs.The role demands
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is seeking a Senior Director of Economic Modeling to lead the strategy and execution of health economic models across its portfolio. You will work with Global HEOR & RWE to support HTA submissions and payer
Location of role Zug, Switzerland Department Medical Affairs - EU Key Responsibilities The Autoimmune Research team has, in recent years, advanced novel therapeutic approaches to modulate and suppress the immune system in a targeted manner within